Related Experiment Video
Updated: Jan 21, 2026
09:47
Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
2.8K
Managing Vasoactive Medications Following Cardiothoracic Surgery
Michael Petty1, Kathleen Kopp1
1Cardiovascular ICU (Unit 4E), University of Minnesota Medical Center, 500 Harvard Street Southeast, Minneapolis, MN 55455, USA.
Critical Care Nursing Clinics of North America
|July 29, 2019
Summary
This review covers vasoactive medications for cardiac surgery patients, focusing on their impact on cardiac output and blood pressure. It guides decisions on medication use, titration, and discontinuation in postoperative care.
Area of Science:
- Cardiology
- Pharmacology
- Critical Care Medicine
Background:
- Postoperative cardiac surgery patients often require hemodynamic support.
- Vasoactive medications are crucial for managing blood pressure and cardiac output in this population.
Purpose of the Study:
- To review the use of vasoactive medications in postoperative cardiac surgery.
- To elucidate the influence of these drugs on cardiac output and blood pressure.
- To provide guidance on decision-making for the use, titration, and discontinuation of vasoactive agents.
Main Methods:
- Literature review of vasoactive medication use in cardiac surgery.
- Analysis of the physiologic effects of vasoactive drugs on hemodynamics.
- Inclusion of case studies for practical application.
Main Results:
- Vasoactive medications significantly impact cardiac output and blood pressure post-cardiac surgery.
- Understanding drug mechanisms is key to effective hemodynamic management.
- Clinical decision-making frameworks for these medications are essential.
Conclusions:
- Optimizing vasoactive medication strategies improves patient outcomes after cardiac surgery.
- Evidence-based guidelines aid in the safe and effective use of these agents.
- Continuous learning and case study analysis enhance clinical practice.
More Related Videos
Related Concept Videos
01:30Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227
01:18Endocarditis III: Medical Management
217
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
217
01:14Myocarditis III: Medical Management
182
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
182
01:17Pericarditis III: Medical Management
321
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
321
01:26Mitral Stenosis III: Medical Management
253
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
253
01:25Aortic Regurgitation III: Medical Management
406
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
406